XT
INDV icon

XTX Topco’s Indivior Pharmaceuticals INDV Stock Holding History

XTX Topco’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$506K Sell
12,327
-5,049
-29% -$183K 0.01% 2439
2026
Q1 		$530K Buy
+17,376
New +$574K 0.01% 1995
2025
Q2 		– Sell
-50,437
Closed -$481K – 2741
2025
Q1 		$481K Buy
50,437
+27,906
+124% +$293K 0.02% 1061
2024
Q4 		$280K Sell
22,531
-110,663
-83% -$1.14M 0.02% 1286
2024
Q3 		$1.3M Buy
133,194
+117,767
+763% +$1.38M 0.09% 313
2024
Q2 		$249K Buy
+15,427
New +$278K 0.02% 1083

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco's INDV Position: Q2 2026 in Review

XTX Topco reduced its Indivior Pharmaceuticals (INDV) stake by 29% in Q2 2026, selling an estimated $183K and leaving 12,327 shares worth $506K. The position accounts for 0.01% of the portfolio, ranked #2439.

XTX Topco first reported a position in INDV in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.3M in Q3 2024. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • XTX Topco held 12,327 shares of Indivior Pharmaceuticals worth $506K as of Q2 2026.
  • XTX Topco sold 5,049 Indivior Pharmaceuticals shares in Q2 2026, an estimated $183K.
  • Indivior Pharmaceuticals made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2439 holding.
  • XTX Topco first reported a position in Indivior Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • XTX Topco's Indivior Pharmaceuticals position peaked at $1.3M in Q3 2024.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.